Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Andrew S. Hyatt"'
Publikováno v:
Current Opinion in Psychiatry. 35:165-170
Early intervention in first-episode psychosis (FEP) improves symptomatic and functional outcomes while programs last. However, these gains may not be sustained over time and not all individuals benefit equally from such programs. This review examines
Publikováno v:
Psychiatric Services. 72:732-735
The rapid rise of value-based payment (VBP) models presents both new opportunities and challenges for behavioral health providers, especially in health systems that serve low-income and marginalized communities. This column discusses the experience o
Autor:
Andrew S. Hyatt, Kasra Yousefi, Paul L. Nguyen, John Hornberger, Felix Y. Feng, Todd M. Morgan, Darby J. S. Thompson, Ketan K. Badani, Heesun Shin
Publikováno v:
Urology. 86:35-40
To evaluate how a genomic classifier (GC) that predicts the risk of metastasis after prostatectomy would impact adjuvant treatment recommendations made by radiation oncologists and urologists. The 2 specialties often disagree about postprostatectomy
Autor:
Anthony V. D'Amico, Neil E. Martin, Christopher Sweeney, Jim C. Hu, Simon P. Kim, Andrew S. Hyatt, Quoc-Dien Trinh, Jesse D. Sammon, Christopher S. Lathan, Ayal A. Aizer, Paul L. Nguyen, Marianne Schmid, Toni K. Choueiri, David R. Ziehr, Clair J. Beard, Brandon A. Mahal
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 32:1285-1291
Treating high-risk prostate cancer (CaP) with definitive therapy improves survival. We evaluated whether having health insurance reduces racial disparities in the use of definitive therapy for high-risk CaP.The Surveillance, Epidemiology, and End Res
Autor:
Quoc-Dien Trinh, Christopher Sweeney, Anthony V. D'Amico, David R. Ziehr, Joshua A. Beckman, Danjie Zhang, Paul L. Nguyen, Jim C. Hu, Ming-Hui Chen, Andrew S. Hyatt, Karen E. Hoffman, Brandon A. Mahal, Michelle H. Braccioforte, Neil E. Martin, Brian J. Moran, Shehzad Basaria, Clair J. Beard, Toni K. Choueiri
Publikováno v:
BJU International. 116:358-365
Objectives To determine if androgen-deprivation therapy (ADT) is associated with excess cardiac-specific mortality (CSM) in men with prostate cancer and no cardiovascular comorbidity, coronary artery disease risk factors, or congestive heart failure
Autor:
Paul L. Nguyen, Andrew S. Hyatt, Simon P. Kim, Quoc-Dien Trinh, Jim C. Hu, Christopher Sweeney, Anthony V. D'Amico, Karen E. Hoffman, Clair J. Beard, David R. Ziehr, Toni K. Choueiri, Neil E. Martin, Ayal A. Aizer, Brandon A. Mahal
Publikováno v:
Clinical Genitourinary Cancer. 12:e189-e195
Background Men with low-risk prostate cancer (CaP) are considered unlikely to die of CaP and have the option of active surveillance. This study evaluated whether African American (AA) men who present with low-risk disease are at higher risk for death
Autor:
Ayal A. Aizer, Peter F. Orio, Anthony V. D'Amico, Matthew R. Cooperberg, Brandon A. Mahal, Quoc-Dien Trinh, Paul L. Nguyen, Christopher Sweeney, Jim C. Hu, Neil E. Martin, Andrew S. Hyatt, Toni K. Choueiri, Clair J. Beard, David R. Ziehr
Publikováno v:
The American journal of medicine, vol 128, iss 6
Mahal, BA; Cooperberg, MR; Aizer, AA; Ziehr, DR; Hyatt, AS; Choueiri, TK; et al.(2015). Who bears the greatest burden of aggressive treatment of indolent prostate cancer?. American Journal of Medicine, 128(6), 609-616. doi: 10.1016/j.amjmed.2014.12.030. UCSF: Retrieved from: http://www.escholarship.org/uc/item/76g9m53n
Mahal, BA; Cooperberg, MR; Aizer, AA; Ziehr, DR; Hyatt, AS; Choueiri, TK; et al.(2015). Who bears the greatest burden of aggressive treatment of indolent prostate cancer?. American Journal of Medicine, 128(6), 609-616. doi: 10.1016/j.amjmed.2014.12.030. UCSF: Retrieved from: http://www.escholarship.org/uc/item/76g9m53n
© 2015 Elsevier Inc. All rights reserved. Purpose The long-term prostate cancer-specific survival for patients initially managed with active surveillance for low-risk prostate cancer ranges from 97% to 100%. We characterized factors that are associa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da9525f6a364b6deb5d92539ba810f46
https://escholarship.org/uc/item/76g9m53n
https://escholarship.org/uc/item/76g9m53n
Autor:
Philip W. Kantoff, Jessica Milian, Samoneh Kadivar, Joshua A. Beckman, Powell L. Graham, Shehzad Basaria, Paul L. Nguyen, Andrew S. Hyatt, Jonah P. Zuflacht, Petr Jarolim
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Androgen deprivation therapy ( ADT ) is a standard treatment for patients with aggressive prostate cancer. Although ADT improves survival, it increases the risk of diabetes. Emerging evidence suggests that ADT increases adverse cardiovascu
Autor:
Quoc-Dien Trinh, Andrew S. Hyatt, Jim C. Hu, Ming-Hui Chen, Xiangmei Gu, Powell L. Graham, Jason A. Efstathiou, Paul L. Nguyen, Neil E. Martin, Ayal A. Aizer, Toni K. Choueiri
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 13(1)
BACKGROUND Evidence-based consensus guidelines recommend only observation for men with low-risk prostate cancer and life expectancy less than 10 years. This report describes the incidence, drivers, cost, and morbidity of overtreatment of low-risk pro
Autor:
Neil E. Martin, David R. Ziehr, Brandon A. Mahal, Toni K. Choueiri, Andrew S. Hyatt, Paul L. Nguyen, Ayal A. Aizer, Quoc-Dien Trinh, Anthony V. D׳Amico, Clair J. Beard, Aymen Elfiky, Christopher Sweeney, Christopher S. Lathan
Definitive treatment of high-risk prostate cancer with radical prostatectomy or radiation improves survival. We assessed whether racial disparities in the receipt of definitive therapy for prostate cancer vary by regional income.A cohort of 102,486 m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1bce77880cb3e872960e6547ace0fa2
http://hdl.handle.net/11577/3260657
http://hdl.handle.net/11577/3260657